Atualmente muitas são as técnicas utilizadas na área de citogenética para que os desequilíbrios genéticos potencialmente hereditários sejam identificados ou evitados. Algumas das técnicas são utilizadas apenas para o diagnóstico de enfermidades em humanos, mas seria importante que fossem aplicadas também aos animais domésticos, com a finalidade de se associar uma causa genética ao aparecimento de algumas doenças, como por exemplo, os mastocitomas. Os mastocitomas são formações cutâneas neoplásicas originadas de mastócitos e se apresentam com frequência em cães. Algumas raças apresentam maior susceptibilidade ao aparecimento de mastocitoma, e o Boxer tem a maior incidência nesta espécie. Este trabalho objetivou avaliar comparativamente o cariótipo de cães da raça Boxer e buscar uma possível correlação com o desenvolvimento de mastocitoma. Foram utilizadas técnicas citogenéticas de bandamentos C, G e Ron além de análises em coloração convencional (Giemsa). Para tais análises utilizaram-se células cultivadas de linfócitos periféricos e de mastocitomas de Boxer. O material foi analisado e fotografado em microscópio de imersão da marca Zeiss®, em objetiva de 100x, com filtro verde, equipado com software de análise citogenética Ikaros®. Foram consideradas alterações numéricas e estruturais. Foram analisadas 828 metáfases mitóticas provenientes de linfócitos periféricos e células de mastocitomas. A análise das metáfases provenientes de cultura de células dos linfócitos periféricos não apresentou alterações estruturais e a análise numérica mostrou somente uma metáfase com 2n=77, dentre 476 metáfases analisadas. Na análise das metáfases de células tumorais, entre todas as colorações, observou-se que 70,9% apresentou 2n=78, 17,4% mostraram 2n=77; 9,8% 2n=76. Cinco metáfases (1,3%) apresentaram 2n=79 e duas células apresentaram 2n=75. Todas essas alterações numéricas estão relacionadas com alterações estruturais do tipo fusão cêntrica. Os resultados obtidos mostram que devido ao crescimento descontrolado, as células tumorais promovem rearranjos na tentativa de controlar a divisão celular. Ainda, o aprimoramento das técnicas diagnósticas em citogenética promove o conhecimento da biologia tumoral do mastocitoma canino, e consequentemente, possibilita o desenvolvimento de novas estratégias terapêuticas. / Nowadays there are many techniques applyed in cytogenetics in order to identify or avoid potentially hereditary genetic imbalance. Some of the techniques are used only to diagnose human diseases, but it would be important to apply them also to domestic animals, with the purpose of associating a genetic cause with the appearance of some diseases like, for example, mastocytomas. The mastocytomas are neoplasics cutaneous formation originated from mastocitos and frequently appears in dogs. Some breeds show higher susceptibity to the appearance of mastocytoma, and the boxer breed has shown the highest incidence. The objective of this study is to comparatively evaluate the boxer breed chariotype and search for a possible correlation with the mastocytoma development. There has been utilized cytogenetics bandamentos C,G e Ron as well as conventional (Giemsa) coloring analysis. For those analysis there has been utilized cultivated cells from peripheral lynphocites and boxer´s mastocytomas. The material as been analyzed and photographed in a Zeiss immersion microscope, using a 100x objective with green filter, equipped with Ikaros cytogenetic analysis software. It has been considered numerical and structural alterations. There has been analyzed 828 mithotics metaphases from peripheral lynphocites and mastocytomas cells. The analysis of metaphases from the culture of peripheral lynphocites cells did not show structural alterations and the numerical analysis has shown only one metaphase 2n=77, among 476 analyzed metaphases. In the tumoral metaphase cells analysis, among all colorations, it has been observed that 70,9% presented 2n=78, 17,4% shown 2n=77 and 9,8% 2n=76. Five metaphases (1,3%) presented 2n=79 and two cell presented 2n=75. All these numerical alterations are related with structural alterations from the centric fusion type. The obtained results shows that due to the uncontrolled growth, the tumoral cells promote rearrangements in an attempt to control a cellular division. Yet, the improvement of diagnosis technique in cytogenetics promotes the knowledge of canine mastocytoma tumoral biology, and consequently allows the new therapeutic strategy development.

O gênero Rhamdia, popularmente conhecido como jundiá, pertence à família Heptapteridae, uma das maiores radiações de bagres neotropicais de água doce. Estes peixes de médio porte e hábitos oportunistas e noturnos são encontrados em pequenos rios e córregos. No passado, Rhamdia foi considerado um dos gêneros mais especiosos dentro de Siluriformes, contando com cerca de 100 espécies descritas. Entretanto, após uma revisão taxonômica recente o número de espécies desse gênero foi reduzido a 12. Dados genéticos, de natureza cromossômica e molecular, caracterizam o gênero Rhamdia como um grupo que apresenta grande diversidade, sugerindo a existência de complexos de espécies, principalmente para a espécie R. quelen, a única estudada do ponto de vista citogenético até o momento. No presente trabalho, foram utilizadas diferentes metodologias com o intuito de caracterizar cromossomicamente populações de diferentes espécies de Rhamdia, bem como estabelecer as relações evolutivas entre elas, contribuindo para o reconhecimento de padrões e processos evolutivos envolvidos em sua diferenciação. Foram analisados exemplares de R. enfurnada, R. itacaiunas, R. laukidi e R. quelen, provenientes das principais bacias hidrográficas da América do Sul, sendo somadas as análises sequências de genes mitocondriais de R. cinerascens, R. guatemalensis e R. laticauda provenientes do GenBank, totalizando sete das 12 espécies reconhecidas para o gênero. A análise de cinco regiões do genoma mitocondrial identificou a existência de 15 grupos bem definidos e com altos valores de suporte para o que hoje é reconhecido como R. quelen, confirmando a existência de um complexo de espécies. A divisão das espécies de Rhamdia em um grupo Cis-Andino e um grupo Trans-Andino, proposta anteriormente, também foi recuperada, embora o gênero não tenha sido confirmado como monofilético. Os dados citogenéticos permitiram o estabelecimento de tendências de evolução cromossômica dentro do grupo e a sugestão de um possível mecanismo de origem e diferenciação dos cromossomos supranumerários. O presente trabalho reforça a importância da utilização de diferentes abordagens na realização de estudos taxonômicos e evolutivos, sugerindo uma nova revisão do gênero Rhamdia que leve em consideração os dados genéticos obtidos. / The genus Rhamdia, popularly known as jundia, belongs to the family Heptapteridae, one of the greatest radiations within neotropical freshwater catfish. This group of middle-sized fish of opportunistic behavior is found in small rivers and streams. In the past, Rhamdia was considered one of the most specious genera of Siluriformes, comprising about 100 described species. However, after a recent taxonomic review, the number of species within this genus was reduced to 12. Genetic data, whether chromosomal or molecular, have characterized the genus Rhamdia as a high diverse group, suggesting the existence of species complexes, mainly in R. quelen, the only species where cytogenetic data are available so far. In the present work, different methodologies were used in order to characterize cytogenetically populations of distinct species of Rhamdia, as well as their evolutionary relationships, thus contributing to the recognition of evolutionary patterns and processes involved in their differentiation. Specimens of R. enfurnada, R. itacaiunas, R. laukidi and R. quelen, from the main South-American hydrographic basins were analyzed, coupled with sequence analyses of the mitochondrial genes of R. cinerascens, R. guatemalensis and R. laticauda, available in the GenBank, thereby comprising seven of the 12 valid species in the genus. The analysis of five regions of mitochondrial genome identified 15 well-defined groups with high bootstrap values within the so-called R. quelen, confirming the occurrence of a species complex. The division of Rhamdia species into a Cis-Andean group and a Trans- Andean group, as previously proposed, was also revalidated, although the genus seems not to be monophyletic. The cytogenetic data allowed establishing trends of chromosomal evolution within the group and a hypothesis for the origin and differentiation of supernumerary chromosomes could be drawn. The present work reinforces the importance of distinct approaches in taxonomic and evolutionary studies, suggesting a new revision within the genus Rhamdia that takes the present genetic data into account.

Abdominal aortic aneurysms (AAAs), a permanent dilation in the abdominal region of the aorta, is a highly sexually dimorphic disease. AAAs prevalence is ranging from 4-10 fold higher in males than females. Defining the mechanistic basis for reduced (in females) or increased (in males) AAA formation and progression may uncover potential therapeutic targets. The majority of studies examining sexual dimorphism focus on the role of sex hormones. However, genes residing on sex chromosomes, in addition to sex hormones, may contribute to sexual dimorphism of AAAs. For example, the X chromosome contains about 5% of the whole genome, but the role of sex chromosomes genes to sexual dimorphism of cardiovascular diseases such as AAAs is largely unknown. The purpose of this study was to determine the role of sex chromosomes as mediators of sex differences for angiotensin II (AngII)-induced AAAs in hypercholesterolemic mice. We used the four core genotype murine model, which enables the creation of phenotypically normal male and female mice with an XX versus XY sex chromosome complement, to test the hypothesis that an XY sex chromosome complement promotes AngII-induced AAAs. Transgenic male mice expressing the Sry gene on an autosome, but not on the Y-chromosome, were bred to female low-density lipoprotein receptor deficient mice to create male and female mice with an XX or an XY sex chromosome complement. In females, an XY sex chromosome complement doubled the incidence and markedly increased the severity of AngII-induced AAAs. To define mechanisms, we examined gene expression patterns in abdominal aortas and demonstrated elevated expression of inflammatory genes that were linked to increased MMP activity and oxidative stress in aortas from XY females. Moreover, administration of testosterone to XY females, to mimic males, resulted in a striking level of aneurysm rupture. In males, transcriptional profiling of abdominal aortas revealed 450 genes that were influenced by sex chromosomes. Infusion of AngII to XY males resulted in diffuse pathology along the length of the aorta, while XX males developed focal AAAs, with pathology reduced by orchiectomy in both genotypes. Thoracic aortas of XY males exhibited adventitial thickening which was not exist in thoracic aortas from XX males. Following a prolonged period (3 months) of AngII infusions XY males had AAAs with expanded aortic walls, while XX males had thin walled dilated AAAs. In summary, our findings demonstrate a remarkable effect of sex chromosome complement to regulate aortic vasculature and disease development. Aside from demonstrating mechanisms of sexual dimorphism of aortic diseases, these findings indicate that chronic sex hormone therapy in the aging and transgender population may have cardiovascular ramifications. Moreover, identification of targets influenced by sex chromosomes and/or sex hormones in a manner that predicts disease development may identify sex-specific approaches to cardiovascular therapy.

No description available.

Abstract not available

Paget's disease of the bone is a skeletal disorder of unknown cause. This disease is characterised by excessive and abnormal bone remodelling brought about by increased bone resorption followed by disorganised bone formation. Increased bone turnover results in a disorganised mosaic of woven and lamellar bone at affected skeletal sites. This produces bone that is expanded in size, less compact, more vascular, and more susceptible to deformity or fracture than normal bone. Symptoms of Paget's disease may include bone pain, bone deformity, excessive warmth over bone from hypervascularity, secondary arthritis, and a variety of neurologic complications caused in most instances by compression of the neural tissues adjacent to pagetic bone. Genetic factors play a role in the pathogenesis of Paget's disease but the molecular basis remains largely unknown. The identification of the molecular basis of Paget's disease is fundamental for an understanding of the cause of the disease, for identifying subjects at risk at a preclinical stage, and for the development of more effective preventive and therapeutic strategies for the management of the condition. With this in mind, the aim of this project is to identify genetic loci, in a large pedigree, that may harbour genes responsible for Paget's disease of bone. A large Australian family with evidence of Paget's disease was recruited for these studies (Chapter 3). This pedigree has characterised over 250 individuals, with 49 informative individuals affected with Paget's disease of bone, 31 of whom are available for genotypic analysis. The pattern of disease in these individuals is polystotic, with sites of involvement including the spine, pelvis, skull and femur. Although the affected individuals have a severe early-onset form of the disease, the clinical features of the pedigree suggest that the affected family members have Paget's disease and not familial expansile osteolysis (a disease with some similarities to Paget's disease), as our patients have extensive skull and axial skeletal involvement. The disease is inherited as an autosomal dominant trait in the pedigree with high penetrance by the sixth decade. Due to the large size of this family and multiple affected members, this pedigree is a unique resource for the detection of the susceptibility gene in Paget's disease. The first susceptibility loci for Paget's disease of bone have been mapped by other investigators to chromosome 6p21 (PDB1) and 18q21.1-q22 (PDB2) in different pedigrees. Linkage analysis of the Australian pedigree in these studies was performed with markers at PDB1: these data showed significant exclusion of linkage, with LOD scores < - 2 in this region (Chapter 4). Linkage analysis of microsatellite markers from the PDB2 region excluded linkage with this region also, with a 30 cM exclusion region (LOD score < -2.0) centred on D18S42 (Chapter 4). This locus on chromosome 18q21.1-q22 contains a serine protease (serpin) cluster with similarities to chromosome 6p21. Linkage analysis of this region also failed to provide evidence of linkage to this locus (Chapter 4). These data are consistent with genetic heterogeneity of Paget's disease of bone. A gene essential for osteoclast formation encoding receptor activator of nuclear factor-kB (RANK), TNFRSF11A, has been previously mapped to the PDB2 region. Mutations in the TNFRSF11A gene have been identified segregating in pedigrees with Familial Expansile Osteolysis and early onset familial Paget's disease, however, linkage studies and mutation screening have excluded the involvement of RANK in the majority of Paget's disease patients. For the Australian pedigree, mutation screening at the TNFRSF11A locus revealed no mutations segregating with affected individuals with Paget's disease (Chapter 4). Based on these findings, our hypothesis is that a novel susceptibility gene relevant to the pathogenesis of Paget's disease of bone lies elsewhere in the genome in the affected members of this pedigree; this gene should be identifiable using a microsatellite genome-wide scan followed by positional cloning. A genome-wide scan of the Australian pedigree was carried out, followed by fine mapping and multipoint analysis in regions of interest (Chapter 5). The peak 2-point LOD scores from the genome-wide scan were LOD = 2.75 at D7S507 and LOD = 1.76 at D18S70. Two additional regions were also considered for fine mapping: chromosome 19p11-q13.1 with a LOD of 1.58 and chromosome 5q35-qter with a LOD of 1.57. Multipoint and haplotype analysis of markers flanking D7S507 did not support linkage to this region (Chapter 5). Similarly, fine mapping of chromosome 19p11-q13.1 failed to support linkage to this region (Chapter 5). Linkage analysis with additional markers in the region on chromosome 5q35-qter revealed a peak multipoint LOD score of 6.77 (Chapter 5). A distinct haplotype was shown to segregate with all members of the family, except the offspring of III-5 and III-6. Haplotype analysis of markers flanking D18S70 demonstrated a haplotype segregating with Paget's disease in a large sub-pedigree (descendants of III-3 and III-4) (Chapter 5). This sub-pedigree had a significantly lower age at diagnosis than the rest of the pedigree (51.2 + 8.5 vs. 64.2 + 9.7 years, p = 0.0012). Linkage analysis of this sub-pedigree demonstrated a peak two-point LOD score of 4.23 at marker D18S1390 (q = 0.00), and a peak multipoint LOD score of 4.71, at marker D18S70. An implication of these data is that 18q23 harbours a novel modifier gene for reducing the age of onset of Paget's disease of bone. A number of candidate Paget's genes have previously been identified on chromosome 18q23, including the nuclear factor of activated T cells (NFATc1), membrane-associated guanylated kinase (MAGUK) and a zinc finger protein. Candidate gene sequencing of these genes in these studies has failed to identify mutations segregating with affected family members in the sub-pedigree linked to chromosome 18q23 (Chapter 6). More recently, a mutation in the gene encoding the ubiquitin-binding protein sequestosome 1 (SQSTM/p62) has been shown to segregate with affected members of Paget's disease families of French-Canadian origin. In this study, a single base pair deletion (1215delC) was identified as segregating with the majority of affected members in the pedigree (Chapter 6). This deletion introduces a stop codon at amino acid position 392 which potentially results in early termination of the protein and loss of the ubiquitin binding domain. The three affected members of the family that do not share the affected haplotype do not carry a mutation in the coding region of SQSTM/p62. Screening of affected members from 10 further Paget's disease families identified the previously reported P392L mutation in 2 (20%) families. No SQSTM1/p62 coding mutations have been found in the remaining 8 families or in 113 aged matched controls. In conclusion, this project has identified genetic loci and mutations that segregate with individuals affected with Paget's disease. Further investigation of the functional significance of the genetic changes at these loci is expected to lead to a better understanding of the molecular basis of this disease.

Migraine, comprised of migraine with aura (MA) and migraine without aura (MO), is a painful neurovascular disease, affecting approximately 16% of the general population. It is characterised by a wide variety of symptoms including headache, nausea and vomiting, and photo- and phonophobia. The disorder is complex involving not only multiple genes, but also specific environmental factors, which can induce attacks in genetically predisposed individuals. Hyperhomocysteinaemia is a known risk factor for cerebrovascular, peripheral vascular and coronary heart disease. The Methylenetetrahydrofolate Reductase (MTHFR) enzyme is involved in homocysteine metabolism. Furthermore, it has been reported that a homozygous mutation (677C to T; Ala to Val) in the 5,10-MTHFR gene is associated with an elevation in plasma homocysteine levels (Frosst et al., 1995). This common mutation in the MTHFR gene has recently been associated with migraine with aura in a Japanese cohort (Kowa et al., 2000). The present study was designed to determine the prevalence of the MTHFR C677T mutation in Australian patients with migraine and to determine whether this mutation is associated with the disease in Caucasians. A large case-control study, consisting of 270 patients with migraine (167 with aura and 103 without aura), and 270 normal matched controls was investigated. Genotypic results indicated that the prevalence of the homozygous (T/T) genotype in migraine sufferers (15%) was higher than that of controls (9%) (P = 0.084). Furthermore, the frequency of the mutant (T/T) genotype in individuals with MA (19%) was significantly higher than in controls (9%) (P = 0.006). Interestingly, the risk of MA was ~2.5-fold higher in suffers possessing the homozygous variant (OR = 2.52, CI: 1.42 - 4.47, P = 0.0012). To confirm the MTHFR allelic association with MA, family-based tests were performed in an independent pedigrees group, where only those with MA were considered affected. Results from both the Pedigree Disequilibrium Test (PDT) and Family-Based Association Test (FBAT) analysis revealed slight, although not significant (PDT test, P = 132; and FBAT test, P = 0.390), over-transmission of the mutant allele (T) from parents to affected offspring. However, despite the MTHFR variant having a high heterozygosity (0.48), there were a limited number of informative transmissions for the MTHFR variant in the pedigree group resulting in reduced power for these tests. In conclusion, our results support the trends reported in the Japanese migraine study and suggest that the homozygous 677T gene variant causing mild hyperhomocysteinaemia, is a genetic risk factor for migraine, and indicate that further studies investigating the role of this gene are warranted. Mutations in various ion channel genes are responsible for neurovascular and other neurological disorders. Inherited ion channel mutations or "channelopathies" are increasingly found to be the cause of various neurological disorders in humans. Wittekindt and colleagues (1998) reported that the calcium-activated potassium channel (hKCa3) gene is a good candidate for schizophrenia and bipolar disorder (BD), as well as for other neurological disorders such as migraine. The hKCa3 gene is a neuronal small conductance calcium-activated potassium channel, which contains a polyglutamine tract, encoded by a polymorphic CAG repeat in the gene. The hKCa3 gene encodes a protein of 731 amino acids containing two adjacent polyglutamine sequences in its N-terminal domain separated by 25 amino acids. The C-terminal polyglutamine sequence is highly polymorphic in length (Austin et al., 1999). hKCa3 plays a critical role in determining the firing pattern of neurons via the generation of slow after-polarization pulses and the regulation of intracellular calcium channels (Kohler et al., 1996). Three distinct mutations in the a1 calcium channel gene have been shown to cause SCA-6, episodic ataxia-2 and familial hemiplegic migraine (FHM) (Ophoff et al., 1996). The hKCa3 gene contains a highly polymorphic CAG repeat that was initially mapped (Chandy et al., 1997) to a schizophrenia locus on chromosome 22 (Pulver et al., 1994). Recently Austin et al (1999) re-mapped hKCa3 and found it to reside on chromosome 1q21, a region that has been linked to FHM (Austin et al., 1999), a rare subtype of MA (Ducros et al., 1997; Gardner et al., 1998), and a region recently showing genetic linkage to typical migraine (Lea et al., 2002). The hKCa3 polymorphism results in small variations in polyglutamine number, similar to those that occur in the calcium channel a1a subunit gene (CACNA1A), which is encoded by CAG expansions and thought to cause Spinocerebellar Ataxia Type 6 via loss of channel function (Austin et al., 1999). Given the recent linkage of FHM to the region of chromosome 1q21, to which hKCa3 resides, and also linkage of typical migraine to this region, a large case-control study investigating this hKCa3 CAG marker and consisting of 270 migraine and 270 stringently matched healthy controls was undertaken. Our results indicated that there was no statistically significant difference in allele distributions for this marker between migraine and non-migraine patients (P >0.05). No significant difference in the allelic distribution was observed in the MA or MO groups when compared to controls (P >0.05) and there was no significant difference in CAG repeat length distribution between the migraine group and controls (P = 0.92), or between the MA and MO groups (P = 0.72) collectively. Hence, the CAG repeat in this gene does not show expansion in migraine. Overall, our results provide no genetic evidence to suggest that the hKCa3 CAG repeat polymorphism is involved in migraine aetiology in Australian Caucasians. Thus the involvement of the hKCa3 gene in migraine is not likely, although the hKCa3 gene remains an important candidate for other neurological disorders that may be linked to the 1q21.3 chromosomal region.

Microsatellites are simple repetitive DNA sequences that are used as genetic markers throughout the biological sciences. The high levels of variation observed at microsatellite loci contribute to their utility in studies at the population and individual levels. This variation is a consequence of mutations that change the length of microsatellite repeat tracts. Current understanding suggests that most mutations are caused by polymerase slippage during DNA replication and lead to changes of a single repeat unit in length, but some changes involving multiple repeats can also occur. Despite this simplistic overview, there is evidence for considerable heterogeneity in mutation processes between species, loci and alleles. Such complex patterns suggest that other mechanisms, including those associated with DNA recombination, are also involved in the generation of microsatellite mutations. Understanding which mutational mechanisms are responsible for variation at microsatellite markers is essential to enable accurate data interpretation in genotyping projects, as many commonly used statistics assume specific mutation models. I developed microsatellite markers specific to the X and Y chromosomes and an autosome in the tammar wallaby, Macropus eugenii, and investigated their evolutionary properties using two approaches: indirectly, as inferred from population data, and directly, from observation of mutation events. First, I found that allelic richness increased with repeat length and that two popular mutation models, the stepwise mutation model and the infinite allele model, were poor at predicting the number of alleles per locus, particularly when gene diversity was high. These results suggest that neither model can account for all mutations at tammar wallaby microsatellites and hint at the involvement of more complex mechanisms than replication slippage. I also determined levels of variation at each locus in two tammar wallaby populations. I found that allelic richness was highest for chromosome 2, intermediate for the X chromosome and lowest for the Y chromosome in both populations. Thus, allelic richness varied between chromosomes in the manner predicted by their relative exposure to recombination, although these results may also be explained by the relative effective population sizes of the chromosomes studied. Second, I used small-pool PCR from sperm DNA to observe de novo mutation events at three of the most polymorphic autosomal markers. To determine the reliability of my observations I developed and applied strict criteria for scoring alleles and mutations at microsatellite loci. I observed mutations at all three markers, with rate variation between loci. Single step mutations could not be distinguished because of the limitations of the approach, but 24 multi-step mutations, involving changes of up to 35 repeat units, were recorded. Many of these mutations involved changes that could not be explained by the gain or loss of whole repeat units. These results imply that a large number of mutations at tammar wallaby microsatellites are caused by mechanisms other than replication slippage and are consistent with a role for recombination in the mutation process. Taken as a whole, my results provide evidence for complex mutation processes at tammar wallaby microsatellites. I conclude that careful characterisation of microsatellite mutation properties should be conducted on a case-by-case basis to determine the most appropriate mutation models and analysis tools for each locus. In addition, my work has provided a set of chromosome-specific markers for use in macropod genetic studies, which includes the first marsupial Y chromosome microsatellites. Sex chromosome microsatellites open a new range of possibilities for population studies, as they provide opportunities to investigate gene flow in a male context, to complement data from autosomal and maternally-inherited mitochondrial markers.

Borya mirabilis is one of the world's most critically endangered plants. The research in this thesis has illuminated key aspects of: its reproductive biology; interspecies and intraspecies molecular relationships, mycorrhizal status, tissue culture potential and disease threats. Each of these aspects has fundamental management implications for the active management of B. mirabilis. Floral observations of B. mirabilis and related species affirmed the uniqueness of the Boryaceae amongst the Asparagales. B. mirabilis had an unusually high number of floral abnormalities compared with other species of Borya observed. B. mirabilis is fly-pollinated. Pollen of Borya species showed little difference in the characteristics of mature pollen between species, with viable pollen being prolate and unicolpate with a single colpa-style aperture and a unique patterning of the pila. The structural immaturity of B. mirabilis pollen correlated with evidence from pollen growth experiments, where B. mirabilis pollen had extremely low germination rates, with those grains that did germinate being slow to do so and with slow-growing pollen tubes compared to those of fertile Borya species. Examination of the ovules of B. mirabilis showed that morphologically they were viable compared to viable Borya species. The field population of B. mirabilis was crossed, with one seed produced (the first recorded seed for th is species). Cross-pollination using the pollen of the closely related B. constricta and B. sphaerocephala with B. mirabilis ovules proved unsuccessful. Examination of the chromosome number of B. mirabilis showed that it had approximately 66 chromosomes and is probably hexaploid, relative to the diploid number of 26 in B. constricta. This may explain its low fertility. Interspecies and intraspecies relationships of the Boryaceae and Borya mirabilis were investigated using sequences of chloroplast and nuclear DNA. The closest similarities to B. mirabilis were B. constricta and B. sphaerocephala. B. mirabilis may have emerged from alloploidy of these species in the past. Because of the consistent similarities of B. mirabilis and B. constricta chloroplast sequences, it is proposed that both shared a common ancestor with a chromosome number of 2n=22. A malfunction n meiosis may have resulted in ovules with 2n=44. The high similarity of the nuclear ribosomal ITS region DNA suggests that the nuclear DNA was derived from B. sphaerocephela. B. mirabilis may be an allopolyploid, from fertilisation of a diploid ovule of B. constricta with haploid pollen of B. sphaerocephala, resulting in a reproductively isolated polyploidy of low fertility. The wild population of B. mirabilis was determined to have a small amount of genetic variation. The genetic variation in the field population w as not fully reflected in the ex-situ population. An effective means of micro-propagation of B. nitida for use in B. mirabilis has been established, providing an effective means of mass production of the species. The research has determined: a suitable explant (shoot tips) for regeneration; an effective means of reducing contamination in tissue culture (PPM); what medium is required to micro-propagate the species (LMHM); an appropriate gelling agent (Phytagel); and a practical method for inducing roots on the shoots grown in tissue culture. B. mirabilis has been established as mycorrhizal. The predominant mycorrhizal association is a nodular arbuscular mycorrhiza, present in the form of coils in root nodules over wetter months and as spores in these nodules over dryer months. A significant increase in the health of the ex-situ population of B. mirabilis was recorded after addition of soil containing fine roots of the wild population. Of the plants associated with the wild population, Callitris rhomboidea had the most morphologically similar vesicular arbuscular mycorrhizal relationship. But molecular identification was not achieved due to recalcitrance of DNA in PCR attempts. Potential translocation sites for some of the ex-situ population of B. mirabilis were examined for Phytophthora infestation. Reid's Lookout and Mackey's Peak were infected with P. cinnamomi. Vegetation at Mackey's Peak displayed characteristic infection symptoms, resulted in isolates of P. cinnamomi from baiting and would directly receive runoff from both the walking track and the existing infested B .mirabilis site. At the Reid's Lookout site, both walking track and proposed translocation site were infested with P. cinnamomi, yet did not display the associated symptoms in the vegetation. The Pine Plantation translocation site was uninfected at the level of sampling undertaken. Its vegetation did not display any characteristic infection symptoms and was not isolated when soil samples were baited. It was therefore chosen for translocation and so far the plants are healthy and actively growing. This research has provided critical knowledge to aid the recovery team in its current and future endeavours to manage this species and bring it back from the brink of extinction.

The purpose of this project is to better understand the influences underlying gender differences in the brain using Four Core Genotype mice. Four Core Genotype mice are transgenic mice in which the SRY gene has been translocated from the Y chromosome to another location. This enables separation of the genetic sex and gonadal sex. For example, there are female mice based on sexual organs but their chromosomes are XY(UY- in mice). This allows us to determine whether sexual differentiation in the brain is due to genes or hormones. In this project, I looked at a sexually dimorphic area of the brain, the Bed Nucleus of the Stria Terminalis (BNST), which is twice as large in males than in females. I hypothesize that both chromosomes and gonadal hormones play a part in sexually differentiating the brain including the BNST and thus I predict that the size of the BNST will be the same in XX males (UUSRY) and XY females (UY-). I measured the BNST from five XX female (UU) and five XY male(UY-SRY) four core genotype mouse brains and confirmed that the BNST is larger in males than in females, as it is in normal mice (p= .057). I processed and measured the size of the BNST in ten brains of XX males and XY females to see if the size of the BNST matches the chromosomes or the gonads. The results had a trend in the data that suggested chromosomes play more of an effect on sexual differentiation of the BNST. The overall goal of this project is to contribute to research examining the causes of gender identity in humans by relating this work to other works in the field.